Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1989-5-2
pubmed:abstractText
After T-cell activation, a switch of leucocyte common antigen (LCA) expression occurs which is detected by the disappearance of CD45R and the appearance of UCHL1 positivity. Upon activation of CD45R+ T cells by phytohaemagglutinin (PHA), the IL-2 receptor (IL-2R) develops at 15 hr and blast cells enter the S phase at 20 hr, while remaining UCHL1-. At 40 hr, mitotic cells continue to express CD45R determinants, but weak UCHL1 reactivity is now detectable on 15-20% of these cells. By inhibiting the separation of daughter cells with cytochalasin B, it can be demonstrated that the UCHL1 antigen is newly synthesized in the Golgi apparatus before insertion into the membrane after the first mitosis. At 65 hr after activation, 80% of proliferating cells are UCHL1+. T cells undergo a similar development during allogeneic activation, and specific alloresponsive cells, tested in secondary mixed lymphocyte reaction (MLR), become greatly enriched among the proliferating UCHL1+ cells. Conversely, after a primary MLR, residual CD45R+ T cells are unresponsive to the original stimulus but can still proliferate in response to unrelated alloantigens. These results clarify both the time-course of the acquisition of UCHL1 antigen during the proliferative cycle of activated T cells, and indicate the shift of antigen responsive T-cell populations from the CD45R+ to the UCHL1+ pool.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-2455685, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-2580241, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-2887618, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-2894392, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-2935591, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-2945865, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-2956090, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-2965180, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-2971276, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-2978373, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-3156923, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-3160781, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-6206131, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-6231045, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-6606011, http://linkedlifedata.com/resource/pubmed/commentcorrection/2466769-6790624
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0019-2805
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
213-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Cellular events during memory T-cell activation in vitro: the UCHL1 (180,000 MW) determinant is newly synthesized after mitosis.
pubmed:affiliation
Department of Immunology, Royal Free Hospital School of Medicine, London.
pubmed:publicationType
Journal Article